l-carnitine half-life Acetyl-L-carnitine in chronic pain: A narrative review Changes in carnitine profiles during

The carefully selected components with low molecular weight ensure deep penetration and an intensive effect, resulting in optimal distribution and action in the skins layers

Se recomanda si sa nu se utilizeze suplimente alimentare de tipul D-Carnitina sau DL-Carnitina, intrucat acestea pot bloca efectele pozitive pe care L-Carnitina prezenta deja in organism le are

,

limited clinical data Management: Monitor thyroid function if symptoms of hypothyroidism develop Chemotherapy Agents: Conflicting evidence on interaction with chemotherapy Concern: Taxanes (paclitaxel, docetaxel): Some evidence suggests ALC may worsen CIPN when used during chemotherapy may consider after completion of treatment for established neuropathy Recommendation: Avoid ALC during active chemotherapy